文献速递系统性红斑狼疮

外周血CD8+ T细胞活化与系统性红斑狼疮疾病活动度及治疗抵抗的相关性

Association of peripheral CD8+ T cell activation with disease activity and treatment resistance in systemic lupus erythematosus.
PubMed 文献 · RMD Open · 2025-02-26

该回顾性研究纳入211例系统性红斑狼疮(SLE)患者和48例年龄性别匹配的健康对照,用流式细胞术分析外周血CD8+ T细胞亚群。SLE患者外周血中初始CD8+ T细胞、CD8+终末分化效应记忆细胞和活化CD8+ T细胞(CD38+HLA-DR+)比例显著高于健康对照(p<0.001),活化CD8+ T细胞与抗dsDNA抗体及补体水平相关,并在活动性系统、肾脏或血液学受累患者中显著增高(p<0.05);聚类分析发现活化CD8+ T细胞高、SLE高活动度且伴器官损害(包括活动性肾炎)的亚组在24周治疗后细胞计数持续偏高,提示治疗抵抗。

要点

  • SLE患者外周血初始CD8+ T细胞、CD8+终末分化效应记忆细胞及活化CD8+ T细胞比例均显著高于健康对照(p<0.001)。
  • 活化CD8+ T细胞产生颗粒酶B和干扰素-γ,与血清抗dsDNA抗体(rs=0.3146,p<0.0001)及50%溶血补体单位(rs=-0.3215,p=0.0003)相关。
  • 基于CD8+ T细胞分化和活化的聚类分析识别出活化CD8+ T细胞高、SLE高活动度伴器官损害且24周治疗后细胞计数持续偏高的治疗抵抗亚组。

核心结论

  • 在SLE中,外周血中高细胞毒性和促炎性活化CD8+ T细胞比例增高调节疾病活动度、器官损害和残余治疗抵抗,是潜在治疗靶点。

研究设计与样本

  • 回顾性纳入211例SLE患者和48例年龄、性别匹配的健康对照,采用流式细胞术分析外周血CD8+ T细胞。
  • 主要终点为比较患者与健康对照之间外周血CD8+ T细胞亚群特征。

主要发现

  • SLE患者(平均年龄42.3岁;女性89%;平均病程112.8个月)外周血单个核细胞中初始CD8+ T细胞(CCR7+CD45RA+)、CD8+终末分化效应记忆细胞(CCR7-CD45RA+)和活化CD8+ T细胞(CD38+HLA-DR+)比例显著高于健康对照(p<0.001)。
  • 活化CD8+ T细胞产生颗粒酶B和干扰素-γ,与血清抗dsDNA抗体相关(rs=0.3146,p<0.0001),与50%溶血补体单位相关(rs=-0.3215,p=0.0003)。
  • 活化CD8+ T细胞在活动性系统、肾脏或血液学受累患者中显著增高(p<0.05)。
  • 基于CD8+ T细胞分化和活化的聚类分析亚组分类发现一组活化CD8+ T细胞数量高、SLE高活动度并伴器官损害(包括活动性肾炎)的患者,24周治疗后细胞计数持续偏高,提示治疗抵抗(抗dsDNA抗体滴度高、糖皮质激素剂量高)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Various immune-cell subsets intricately mediate the pathogenesis of systemic lupus erythematosus (SLE). However, the role of CD8+ T cells in SLE remains unclear. We investigated the proportions and characteristics of peripheral CD8+ T cells and their association with clinical manifestations of SLE. METHODS: We retrospectively enrolled 211 patients with SLE and 48 age- and sex-matched healthy controls (HCs). Peripheral CD8+ T cells were analysed using flow cytometry. The primary endpoint was the comparison of peripheral CD8+ T cell subset characteristics between patients and HCs. RESULTS: Patients with SLE (mean age, 42.3 years; women, 89% and mean disease duration, 112.8 months) had significantly higher proportions of naïve CD8+ T cells (CCR7+CD45RA+), CD8+ terminally differentiated effector memory cells (CCR7-CD45RA+) and activated CD8+ T cells (CD38+HLA-DR+) in peripheral blood mononuclear cells than HCs (p<0.001). Activated CD8 + T cells produced granzyme B and interferon-γ, which correlated with serum double-stranded (ds) DNA antibodies (rs=0.3146, p<0.0001) and 50% haemolytic unit of complement (rs=-0.3215, p=0.0003), and were significantly increased in patients with active systemic, renal or haematological involvement (p<0.05). Cluster analysis-based subgroup classification based on CD8 cell differentiation and activation revealed a group with high numbers of activated CD8+ T cells, highly active SLE and organ damage, including active nephritis and persistently high cell counts after a 24-week treatment, indicating treatment resistance (high anti-dsDNA antibody titres and high glucocorticoid doses). CONCLUSION: In SLE, greater proportions of highly cytotoxic and proinflammatory activated CD8+ T cells in peripheral blood-modulated disease activity, organ damage and residual treatment resistance, presenting a potential treatment target.

来源:RMD Open,查看原文。版权归原作者所有。

引用

  1. Fujita Y, Nakayamada S, Kubo S, et al. Association of peripheral CD8+ T cell activation with disease activity and treatment resistance in systemic lupus erythematosus. RMD Open. 2025. PMID: 40010940. doi:10.1136/rmdopen-2024-005122

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。